US states say Sun, Taro generic drug settlements shouldn't limit recovery for citizens
MLex Summary: US state plaintiffs filed a brief in court arguing that they should not be bound by end-payers’ settlement with Sun and Taro in a case over the price-fixing of...To view the full article, register now.
Already a subscriber? Click here to view full article